gp130 signaling in bone cell biology: Multiple roles revealed by analysis of genetically altered mice
- 30 October 2009
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 310 (1-2) , 30-39
- https://doi.org/10.1016/j.mce.2008.08.025
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density inPyk2−/−miceThe Journal of cell biology, 2007
- Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiationJournal of Bone and Mineral Metabolism, 2007
- Impaired skeletal development in interleukin‐6–transgenic mice: A model for the impact of chronic inflammation on the growing skeletal systemArthritis & Rheumatism, 2006
- Null Leukemia Inhibitory Factor Receptor (LIFR) Mutations in Stüve-Wiedemann/Schwartz-Jampel Type 2 SyndromeAmerican Journal of Human Genetics, 2004
- Interaction of interleukin-6 on human granulosa cell steroid secretionJournal of Endocrinology, 2001
- Cloning and Characterization of a Novel Class I Cytokine ReceptorBiochemical and Biophysical Research Communications, 1998
- Recombinant human CNTF receptor .alpha.: production, binding stoichiometry, and characterization of its activity as a diffusible factorBiochemistry, 1994
- Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 ProteinJournal of Cellular Biochemistry, 1994
- Histomorphometric and immunocytochemical studies of src-related osteopetrosisBone, 1993
- The effect of leukemia inhibitory factor on bone in vivoEndocrinology, 1993